LISAvienna: September 2023 newsletter available online
Look forward to an overview of selected news from Vienna, events and funding opportunities. This time the focus is on news on life sciences organizations including thesee: Takeda, ImageBiopsy Lab, Future Health Lab, Myllia Biotechnology, BOKU, ÖGMBT, RIANA Therapeutics, 123sonography, Octapharma, invIOs, MedUni Vienna, CeMM, IMP, University of Vienna, IMBA, UpNano, Holloid, usePAT; Sempermed and Proxygen.
The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.
As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.